Quarterly operating profit growth was 10.1% without FX effects driven by favorable changes in the product portfolio mix and a relatively slower increase of operating expenses, the pharma company Gedeon Richter reports. In addition, no windfall tax was recorded in 2022 Q1. Excluding FX effects Richter’s gross profit increased by 15.3%, driven by a 17.4% […]













